AMN

AMN HEALTHCARE SERVICES INC

Healthcare | Small Cap

$0.37

EPS Forecast

$671.4

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

AMN Healthcare Q3 2026: Revenue Climbs to $717 Million as EPS Lands Near Expectations

AMN Healthcare Services, Inc. (NYSE: AMN) reported its third-quarter 2026 results, with revenue of $717.3 million, adjusted EBITDA of $94 million, GAAP net income of $0.83 per share, and adjusted EPS of $1.16. The company tallies 13% year-over-year revenue growth, and highlights a Dollars in millions, except per share amounts frame for the quarter and the year-to-date total. In plain speak: the numbers look solid, but not seismic, and the stock market will decide whether that’s a win for the multiple expansion crowd or a reminder that growth is a marathon, not a sprint.

Key numbers at a glance

  • Revenue: $717.3 million in Q3 2026; up 13% year over year.
  • Adjusted EBITDA: $94 million.
  • GAAP net income: $33.4 million for the quarter; GAAP diluted EPS of $0.83.
  • Adjusted EPS: $1.16 for the quarter.
  • Gross profit: $229.1 million, with year-over-year growth of about 24%.
  • YTD revenue through September 30, 2026: roughly $2.77 billion.

What the numbers portend

The quarter reads as a demonstration of AMN’s enduring ability to grow revenue while keeping a tight lens on profitability. The 13% Q3 top-line growth signals robust demand for AMN’s “total talent solutions” in healthcare—staffing, placements, and related services that hospitals and health systems rely on as volumes swing and staff mix shifts. The company’s adjusted EBITDA of $94 million underlines that there is operating leverage here, even if the headline margin story isn’t dramatic.

The GAAP EPS of $0.83 versus an adjusted EPS of $1.16 highlights the classic investor tension: the path from GAAP to non-GAAP metrics can be material for judging operating performance, particularly in a labor-intensive business where non-cash adjustments, stock-based compensation, and acquisition-related costs often crowd the numbers.

EPS consensus, earnings surprise, and what’s missing in the narrative

In earnings reporting, analysts typically compare reported EPS to a consensus estimate to gauge a surprise or miss. The press materials for AMN provide GAAP EPS and adjusted EPS figures, but do not clearly quote an explicit EPS consensus or a formal earnings surprise number in the excerpt. That absence means traders will likely scan the conference call and sell-side notes for guidance on whether the quarter’s strength — especially the 24% YoY growth in gross profit — translates into a more confident revenue forecast for the coming quarter and beyond.

The practical effect is that the stock’s reaction will hinge on qualitative cues about demand, pricing discipline, and the trajectory of hiring and providers’ utilization of AMN’s platform. If analysts had been counting on a higher EPS beat, they’ll now calibrate expectations around the cadence of Q4 and the degree to which the company can convert gross-profit momentum into sustained bottom-line improvement.

Implications for AMN and sector peers

AMN’s positioning as a “leader and innovator in total talent solutions for healthcare organizations” matters beyond a single quarterly print. In a broader healthcare staffing landscape, steady demand for talent solutions suggests hospitals are continuing to optimize workforce mix — balancing permanent placements with flexible staffing to manage patient load and cost.

For sector peers, the quarter reinforces a few themes: the durability of demand for healthcare labor platforms; the importance of cost discipline and productivity in a high-output staffing model; and the ongoing potential for non-GAAP measures to tell a more complete story about operating leverage. If AMN can sustain double-digit revenue growth while maintaining strong adjusteda EBITDA, the sector may see multiple valuation anchors re-priced toward growth stories with stable cash generation.

What to watch next

Investors will be listening for a few signals as AMN moves toward the next quarter:

  • Revenue forecast and commentary on demand stability in key specialties and geographies.
  • Trends in the mix between temporary staffing and permanent placement, and how that affects margins.
  • Any changes to the cadence of acquisition activity or platform investment that could alter the growth outlook.
  • Management’s assessment of wage pressures, utilization rates, and client retention in the backdrop of a competitive labor market.

In short, the revenue forecast and any guidance on earnings trajectory will be the primary driver of the stock’s direction after the initial press release, especially given the absence of an explicit EPS consensus in the filing we’ve seen. Still, the quarter’s numbers provide a readable ledger: solid top-line growth, healthy gross profit expansion, and a clear path to a sustainable adjusted earnings profile if the company can keep execution tight.

Note: This summary reflects the quarter ended September 30, 2026 as disclosed by AMN Healthcare Services, Inc. in Exhibit 99.1 and accompanying materials. Ticker references, EPS figures, and revenue data are presented as reported for Q3 2026.